Business briefing for May 8

Nylon maker Ascend files for bankruptcy Struggling with debt and a market swamped with overcapacity, the nylon 6,6 producer Ascend Performance Materials has declared bankruptcy in Texas. It has secured $250 million in debtor-in-possession financing that will allow it to continue running until it wraps up the restructuring process in about 6 months. Headquartered in Houston, Ascend makes nylon 6,6 and its precursors, acrylonitrile, adiponitrile, adipic acid, and hexamethylenediamine. The company had sales of $2.4 billion in 2023. The New York City–based private equity firm SK Capital bought the business from Solutia in 2009 for the bargain price of $50 million in cash. Ascend blames the bankruptcy on its underlying financial structure and high debt obligations. This past February, S&P downgraded its rating for Ascend because of underperformance in 2024 and a “challenging operating environment.” Last year, Ascend closed its compounding plant in Tilburg, the Netherlands. Earlier this year, the

Publication Details

Journal
C&EN Global Enterprise
Published
2025-05-05
DOI
https://doi.org/10.1021/cen-10312-buscon6
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Business briefing for May 8

1 links
C&EN Global Enterprise
Biotechnology and Related Fields
article

Business briefing for May 8

article en

Abstract

Nylon maker Ascend files for bankruptcy Struggling with debt and a market swamped with overcapacity, the nylon 6,6 producer Ascend Performance Materials has declared bankruptcy in Texas. It has secured $250 million in debtor-in-possession financing that will allow it to continue running until it wraps up the restructuring process in about 6 months. Headquartered in Houston, Ascend makes nylon 6,6 and its precursors, acrylonitrile, adiponitrile, adipic acid, and hexamethylenediamine. The company had sales of $2.4 billion in 2023. The New York City–based private equity firm SK Capital bought the business from Solutia in 2009 for the bargain price of $50 million in cash. Ascend blames the bankruptcy on its underlying financial structure and high debt obligations. This past February, S&P downgraded its rating for Ascend because of underperformance in 2024 and a “challenging operating environment.” Last year, Ascend closed its compounding plant in Tilburg, the Netherlands. Earlier this year, the

C&EN Global EnterpriseVol. 103(12)
Openalex Percentile: Top 87%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Business briefing for May 8 · C&EN Global Enterprise (2025) | TGRS Research Map | TGRS